Farmacias Benavides SAB de CV Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Million

Consolidate Quarterly Results

Mar'26

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Net Sales

5,738.20

5,462.02

4,890.34

4,642.20

4,463.96

4,400.94

4,251.08

Other Operating Income

0.00

Total Operating income

5,738.20

5,462.02

4,890.34

4,642.20

4,463.96

4,400.94

4,251.08

Raw Material Cost

4,154.00

4,134.25

3,433.95

3,214.32

3,039.36

2,991.15

3,146.61

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

671.23

0.00

606.73

613.55

608.95

340.35

547.46

Power Cost

0.00

Manufacturing Expenses

131.78

105.66

116.38

124.47

122.46

123.86

119.97

Selling and Distribution Expenses

1,290.36

997.87

1,198.87

1,190.24

1,196.45

1,204.53

911.26

Other Expenses

-80.30

-10.57

-72.31

-73.80

-73.14

-46.42

-66.74

Total Expenditure (Excl Depreciation)

5,444.35

5,132.12

4,632.82

4,404.55

4,235.81

4,195.67

4,057.88

Operating Profit (PBDIT) excl Other Income

293.8

329.90000000000003

257.5

237.60000000000002

228.2

205.3

193.2

Other Income

8.97

6.58

26.35

31.77

15.72

-29.16

29.82

Operating Profit (PBDIT)

591.04

613.28

545.02

528.58

504.64

437.93

487.78

Interest

131.78

105.66

116.38

124.47

122.46

123.86

119.97

Exceptional Items

0.00

Gross Profit (PBDT)

1,584.20

1,327.78

1,456.40

1,427.88

1,424.60

1,409.79

1,104.46

Depreciation

288.22

276.79

261.14

259.16

260.76

261.82

264.76

Profit Before Tax

171.04

230.83

167.50

144.95

121.42

52.25

103.05

Tax

66.88

111.63

34.23

46.37

30.53

155.14

3.52

Provisions and contingencies

0.00

Profit After Tax

104.16

119.20

133.27

98.58

90.89

-102.89

99.53

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

104.16

119.20

133.27

98.58

90.89

-102.89

99.53

Share in Profit of Associates

0.00

Minority Interest

0.00

Other related items

0.00

Consolidated Net Profit

104.16

119.20

133.27

98.58

90.89

-102.89

99.53

Equity Capital

0.00

Face Value

0.0

Reserves

863.29

759.13

882.09

748.82

658.33

567.44

642.77

Earnings per share (EPS)

0.25

0.29

0.33

0.24

0.22

-0.25

0.24

Diluted Earnings per share

0.25

0.29

0.33

0.24

0.22

-0.25

0.24

Operating Profit Margin (Excl OI)

5.12%

6.04%

5.27%

5.12%

5.11%

4.66%

4.54%

Gross Profit Margin

8.0%

9.29%

8.77%

8.71%

8.56%

7.14%

8.65%

PAT Margin

1.82%

2.18%

2.73%

2.12%

2.04%

-2.34%

2.34%

Public Share Holdings (%)

0.0%

Pledged Promotor Holding (%)

0.0%

Quarterly Analysis Highlights - YoY

Net Sales

YoY Growth in quarter ended Mar 2026 is 28.54% vs -3.19% in Mar 2025

Consolidate Net Profit

YoY Growth in quarter ended Mar 2026 is 14.63% vs 56.99% in Mar 2025

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Mar 2026 is 19.06% vs 5.19% in Mar 2025

Interest

YoY Growth in quarter ended Mar 2026 is 7.59% vs 6.71% in Mar 2025

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025

Compare Quarterly Results Of Farmacias Benavides SAB de CV With

Select Peers

Figures in Million

Consolidate Quarterly Results

Change(MXN)

Change(%)

Net Sales

5,738.20

34,673.14

-28,934.94

-83.45%

Other Operating Income

0.00

Total Operating income

5,738.20

34,673.14

-28,934.94

-83.45%

Raw Material Cost

4,154.00

26,077.93

-21,923.93

-84.07%

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

671.23

0.00

671.23

Power Cost

0.00

Manufacturing Expenses

131.78

373.40

-241.62

-64.71%

Selling and Distribution Expenses

1,290.36

7,108.66

-5,818.30

-81.85%

Other Expenses

-80.30

-37.34

-42.96

-115.05%

Total Expenditure (Excl Depreciation)

5,444.35

33,186.59

-27,742.24

-83.59%

Operating Profit (PBDIT) excl Other Income

293.85

1,486.55

-1,192.70

-80.23%

Other Income

8.97

995.74

-986.77

-99.10%

Operating Profit (PBDIT)

591.04

2,912.37

-2,321.33

-79.71%

Interest

131.78

373.40

-241.62

-64.71%

Exceptional Items

0.00

Gross Profit (PBDT)

1,584.20

8,595.21

-7,011.01

-81.57%

Depreciation

288.22

430.08

-141.86

-32.98%

Profit Before Tax

171.04

2,108.89

-1,937.85

-91.89%

Tax

66.88

874.10

-807.22

-92.35%

Provisions and contingencies

0.00

Profit After Tax

104.16

1,234.79

-1,130.63

-91.56%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

104.16

1,234.79

-1,130.63

-91.56%

Share in Profit of Associates

0.00

Minority Interest

0.00

0.01

-0.01

-100.00%

Other related items

0.00

Consolidated Net Profit

104.16

1,234.79

-1,130.63

-91.56%

Equity Capital

0.00

Face Value

0.00

Reserves

863.29

29,052.44

-28,189.15

-97.03%

Earnings per share (EPS)

0.25

12.89

-12.64

-98.06%

Diluted Earnings per share

0.25

12.89

-12.64

-98.06%

Operating Profit Margin (Excl OI)

5.12%

4.29%

0.00

0.83%

Gross Profit Margin

8.00%

7.32%

0.00

0.68%

PAT Margin

1.82%

3.56%

0.00

-1.74%

Public Share Holdings (%)

0.00

0.00%

Pledged Promotor Holding (%)

0.00

0.00%

Quarterly - Net Sales

Net Sales 573.82 Million

in Mar 2026

Figures in Million

QoQ Growth in quarter ended Mar 2026 is 5.06% vs 11.69% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 28.54% vs -3.19% in Mar 2025

Quarterly - Consolidate Net Profit

Consolidate Net Profit 10.42 Million

in Mar 2026

Figures in Million

QoQ Growth in quarter ended Mar 2026 is -12.58% vs -10.58% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 14.63% vs 56.99% in Mar 2025

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 58.21 Million

in Mar 2026

Figures in Million

QoQ Growth in quarter ended Mar 2026 is -4.05% vs 16.97% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 19.06% vs 5.19% in Mar 2025

Quarterly - Interest

Interest 13.18 Million

in Mar 2026

Figures in Million

QoQ Growth in quarter ended Mar 2026 is 24.69% vs -9.19% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 7.59% vs 6.71% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 5.12%

in Mar 2026

Figures in %

QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025